These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1406 related items for PubMed ID: 10202164
21. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Sundfør K, Tropé CG, Högberg T, Onsrud M, Koern J, Simonsen E, Bertelsen K, Westberg R. Cancer; 1996 Jun 01; 77(11):2371-8. PubMed ID: 8635109 [Abstract] [Full Text] [Related]
23. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, Weitmann H, Reinthaller A, Knocke TH, Wachter S, Kirisits C. Radiother Oncol; 2007 May 01; 83(2):148-55. PubMed ID: 17531904 [Abstract] [Full Text] [Related]
24. Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience. Rath GK, Sharma DN, Julka PK, Subramani V, Bahl A, Haresh KP. Am J Clin Oncol; 2010 Jun 01; 33(3):238-41. PubMed ID: 19841576 [Abstract] [Full Text] [Related]
25. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Yang SN, Lin FJ. Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1370-7. PubMed ID: 16979836 [Abstract] [Full Text] [Related]
26. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Falkenberg E, Kim RY, Meleth S, De Los Santos J, Spencer S. Brachytherapy; 2006 Dec 01; 5(1):49-55. PubMed ID: 16563997 [Abstract] [Full Text] [Related]
27. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E. Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093 [Abstract] [Full Text] [Related]
28. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results. Liang JA, Chen SW, Chang WC, Hung YC, Yeh LS, Yang SN, Lin FJ. Clin Oncol (R Coll Radiol); 2008 Nov 01; 20(9):683-90. PubMed ID: 18676129 [Abstract] [Full Text] [Related]
29. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors. Kim YB, Cho JH, Keum KC, Lee CG, Seong J, Suh CO, Kim GE. Gynecol Oncol; 2007 Jan 01; 104(1):58-63. PubMed ID: 16919718 [Abstract] [Full Text] [Related]
31. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity. Delpech Y, Haie-Meder C, Rey A, Zafrani Y, Uzan C, Gouy S, Pautier P, Lhommé C, Duvillard P, Castaigne D, Morice P. Ann Surg Oncol; 2007 Nov 01; 14(11):3223-31. PubMed ID: 17713822 [Abstract] [Full Text] [Related]
32. Optimal management of locally advanced cervical carcinoma. Keys H, Gibbons SK. J Natl Cancer Inst Monogr; 1996 Nov 01; (21):89-92. PubMed ID: 9023835 [Abstract] [Full Text] [Related]
33. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study. Rose PG, Ali S, Whitney CW, Lanciano R, Stehman FB. Gynecol Oncol; 2011 Jun 01; 121(3):542-5. PubMed ID: 21420157 [Abstract] [Full Text] [Related]
34. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
35. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study. Zhang MQ, Liu SP, Wang XE. Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):821-7. PubMed ID: 20207507 [Abstract] [Full Text] [Related]
36. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Hwang YY, Moon H, Cho SH, Kim KT, Moon YJ, Kim SR, Kim DS. Gynecol Oncol; 2001 Jul 01; 82(1):88-93. PubMed ID: 11426967 [Abstract] [Full Text] [Related]
37. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences. Sorbe B, Bohr L, Karlsson L, Bermark B. Int J Oncol; 2010 Feb 01; 36(2):371-8. PubMed ID: 20043071 [Abstract] [Full Text] [Related]
38. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA. Kornovski Y, Gorchev G. J BUON; 2006 Feb 01; 11(3):291-7. PubMed ID: 17309152 [Abstract] [Full Text] [Related]
39. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group. Stehman FB, Bundy BN, Kucera PR, Deppe G, Reddy S, O'Connor DM. Gynecol Oncol; 1997 Aug 01; 66(2):262-7. PubMed ID: 9264574 [Abstract] [Full Text] [Related]
40. Combined chemotherapy and radiation for bulky stages I-II cervical cancer: comparison of concurrent and sequential regimens. Park TK, Lee SK, Kim SN, Hwang TS, Kim GE, Suh CO, Loh JK. Gynecol Oncol; 1993 Aug 01; 50(2):196-201. PubMed ID: 8375735 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]